Psoriasis

Top Story

FDA approves Taltz for pediatric psoriasis

March 30, 2020
In the Journals

Etanercept may have utility in psoriasis among patients with inadequate apremilast response

March 23, 2020
Among patients with psoriasis who showed an inadequate response to apremilast, etanercept was associated with strong response rates and patient-reported outcomes…
In the Journals

Adalimumab trials show low rate of IBD adverse events

March 16, 2020
A review of 75 adalimumab clinical trials in adult and pediatric patients demonstrated low rates of inflammatory bowel disease adverse events, according to data…
In the Journals

Sociodemographic background may affect ‘not relevant’ responses on DLQI

March 12, 2020
Gender, income and marital status may predict the likelihood of reporting “not relevant” to certain questions on the Dermatology Life Quality Index among…
More Headlines »
Healio Jobs